HTFL insider trading — Heartflow, Inc.
No open-market insider purchases or sales were filed for Heartflow, Inc. (HTFL) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent HTFL insider transactions
Every Form 4 filed by Heartflow, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 38,900 | $49.57 | $1.93M | Form 4 |
| Sep 18, 2026 | Rogers Campbell | Chief Medical Officer | M · Option exercise · 10b5-1 | Direct | 13,179 | $7.94 | $105K | Form 4 |
| Sep 18, 2026 | Rogers Campbell | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 19,682 | $50.15 | $987K | Form 4 |
| Sep 18, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 16,766 | $50.75 | $851K | Form 4 |
| Sep 17, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 7,579 | $50.11 | $380K | Form 4 |
| Sep 15, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 668 | $50.01 | $33K | Form 4 |
| Sep 14, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 4,593 | $50.24 | $231K | Form 4 |
| Sep 11, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 29,714 | $50.06 | $1.49M | Form 4 |
| Sep 11, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 3,890 | $50.00 | $194K | Form 4 |
| Sep 10, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 35,010 | $46.42 | $1.63M | Form 4 |
| Sep 8, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 6,640 | $50.03 | $332K | Form 4 |
| Sep 3, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 27,540 | $49.69 | $1.37M | Form 4 |
| Sep 2, 2026 | Verghese Vikram | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 5,876 | $50.60 | $297K | Form 4 |
| Aug 21, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 27,230 | $50.00 | $1.36M | Form 4 |
| Aug 18, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 32,676 | $45.00 | $1.47M | Form 4 |
| Aug 17, 2026 | Rogers Campbell | Chief Medical Officer | M · Option exercise · 10b5-1 | Direct | 9,219 | $19.00 | $175K | Form 4 |
| Aug 17, 2026 | Rogers Campbell | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 9,219 | $41.23 | $380K | Form 4 |
| Aug 14, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 15,560 | $39.06 | $608K | Form 4 |
| Aug 10, 2026 | Farquhar John C.M. | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 22,562 | $28.31 | $639K | Form 4 |
| Aug 7, 2026 | Jones Marie L. | Chief Accounting Officer | F · Tax withholding | Direct | 82 | $28.82 | $2K | Form 4 |
| Aug 6, 2026 | Jones Marie L. | Chief Accounting Officer | F · Tax withholding | Direct | 486 | $27.19 | $13K | Form 4 |
| Mar 6, 2026 | Jones Marie L. | Chief Accounting Officer | A · Grant/award | Direct | 1,661 | $16.15 | $27K | Form 4 |
| Aug 7, 2026 | Verghese Vikram | Chief Financial Officer | F · Tax withholding | Direct | 473 | $28.82 | $14K | Form 4 |
| Aug 6, 2026 | Verghese Vikram | Chief Financial Officer | F · Tax withholding | Direct | 1,537 | $27.19 | $42K | Form 4 |
| Mar 6, 2026 | Verghese Vikram | Chief Financial Officer | A · Grant/award | Direct | 671 | $16.15 | $11K | Form 4 |
| Aug 7, 2026 | Rogers Campbell | Chief Medical Officer | F · Tax withholding | Direct | 637 | $28.82 | $18K | Form 4 |
| Aug 6, 2026 | Rogers Campbell | Chief Medical Officer | F · Tax withholding | Direct | 1,635 | $27.19 | $44K | Form 4 |
| Aug 7, 2026 | Farquhar John C.M. | Chief Executive Officer | F · Tax withholding | Direct | 1,904 | $28.82 | $55K | Form 4 |
| Aug 6, 2026 | Farquhar John C.M. | Chief Executive Officer | F · Tax withholding | Direct | 5,847 | $27.19 | $159K | Form 4 |
| Jul 30, 2026 | Farquhar John C.M. | Chief Executive Officer | M · Option exercise | Direct | 31,220 | $5.06 | $158K | Form 4 |
| Jul 27, 2026 | Verghese Vikram | Chief Financial Officer | M · Option exercise | Direct | 22,522 | $2.22 | $50K | Form 4 |
| Jul 24, 2026 | Lightcap Jeffrey C | Director | M · Option exercise | Direct | 47,420 | $19.00 | $901K | Form 4 |
| Jul 22, 2026 | Barabe Timothy C | Director | M · Option exercise | Direct | 3,710 | $19.00 | $70K | Form 4 |
| Jul 21, 2026 | Verghese Vikram | Chief Financial Officer | M · Option exercise | Direct | 22,522 | $2.22 | $50K | Form 4 |
| Jul 17, 2026 | Barabe Timothy C | Director | M · Option exercise | Direct | 5,000 | $19.00 | $95K | Form 4 |
HTFL insider trading FAQ
Are insiders buying HTFL stock?
Not on the open market. In the last 90 days, Heartflow, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading HTFL?
No insider bought or sold on the open market in the last 90 days.
Where does HTFL insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.